Tenet Healthcare (THC) Stock Price, News & Analysis

Company Overview

Tenet Healthcare Corporation is a Dallas-based healthcare services company that operates hospitals, outpatient facilities and other healthcare businesses across the United States. Its operations include acute care hospitals, specialty hospitals, ambulatory surgery centers and related outpatient services.

Through its United Surgical Partners International subsidiary, Tenet is one of the major operators and developers of ambulatory surgery centers in the United States. These facilities provide same-day surgical procedures and other outpatient care across a range of medical specialties. Tenet also provides revenue-cycle management, patient administration and other support services to healthcare organizations through its Conifer Health Solutions business.

The company traces its history to 1967 and was formerly known as National Medical Enterprises before adopting the Tenet Healthcare name in 2003. Tenet’s operations primarily serve communities throughout the United States. Saum Sutaria, M.D., has served as the company’s president and chief executive officer since 2022.

Key Stats

• Today's Range: $258.75 to $263.23
• 50-Day Range: $242.42 to $280.60
• 52-Week Range: $157.58 to $283.05
• Volume: 70,903 shs
• Average Volume: 1.16 million shs
• Market Capitalization: $21.13 billion
• P/E Ratio: 10.13
• Dividend Yield: N/A
• Price Target: $277.25
• Consensus Rating: Moderate Buy

Tenet Healthcare Stock Analysis - MarketRank™

Tenet Healthcare scored higher than 63% of companies evaluated by MarketBeat, and ranked 287th out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Tenet Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on no strong buy ratings, 18 buy ratings, 3 hold ratings, and no sell ratings.

Upside/Downside

The consensus price target for Tenet Healthcare is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Tenet Healthcare has been the subject of 17 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: -1.09%

Earnings Growth

Earnings for Tenet Healthcare are expected to decrease by -1.09% in the coming year, from $21.04 to $20.81 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Tenet Healthcare is 10.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.65.

Price to Earnings Ratio vs. Sector

The P/E ratio of Tenet Healthcare is 10.00, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.00.

Price to Earnings Growth Ratio

Tenet Healthcare has a PEG Ratio of 0.99. PEG Ratios around 1 indicate that a company is correctly valued.

Price to Book Value per Share Ratio

Tenet Healthcare has a P/B Ratio of 3.75. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.53% of the float of Tenet Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Tenet Healthcare has a short interest ratio ("days to cover") of 2.81, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Tenet Healthcare has recently increased by 6.78%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Tenet Healthcare does not currently pay a dividend.

Dividend Growth

Tenet Healthcare does not have a long track record of dividend growth.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.26

News Sentiment

Tenet Healthcare has a news sentiment score of 0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.44 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 7 news articles for Tenet Healthcare this week, compared to 5 articles on an average week.

Search Interest

Only 2 people have searched for THC on MarketBeat in the last 30 days. This is a decrease of -89% compared to the previous 30 days.

MarketBeat Follows

3 people have added Tenet Healthcare to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Tenet Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $35,065,587.00 in company stock.

Percentage Held by Insiders

0.97% of the stock of Tenet Healthcare is held by insiders.

Percentage Held by Institutions

95.44% of the stock of Tenet Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/23/2026
• Today: 10/05/2026
• Next Earnings (Confirmed): 10/29/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Facilities
• Current Symbol: NYSE:THC
• CIK: 70318
• Web: www.tenethealth.com
• Phone: (469) 893-2200
• Fax: 469-893-8600
• Employees: 99,000
• Year Founded: 1969

Price Target and Rating

• Average Price Target for Tenet Healthcare: $277.25
• High Price Target: $309.00
• Low Price Target: $225.00
• Potential Upside/Downside: +5.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.86
• Research Coverage: 21 Analysts

Profitability

• EPS (Trailing Twelve Months): $25.93
• Trailing P/E Ratio: 10.12
• Forward P/E Ratio: 12.47
• P/E Growth: 0.99
• Net Income: $1.41 billion
• Net Margins: 10.27%
• Pretax Margin: 17.72%
• Return on Equity: 26.76%
• Return on Assets: 5.55%

Debt

• Debt-to-Equity Ratio: 2.00
• Current Ratio: 1.41
• Quick Ratio: 1.35

Sales & Book Value

• Annual Sales: $21.31 billion
• Price / Sales: 0.99
• Cash Flow: $28.13 per share
• Price / Cash Flow: 9.33
• Book Value: $69.19 per share
• Price / Book: 3.79

Miscellaneous

• Outstanding Shares: 80,520,000
• Free Float: 79,738,000
• Market Cap: $21.13 billion
• Optionable: Optionable
• Beta: 1.20